Business Description
Kmpharmaceutical Co Ltd
ISIN : KR7225430008
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.08 | |||||
Equity-to-Asset | 0.7 | |||||
Debt-to-Equity | 0.35 | |||||
Debt-to-EBITDA | 12.22 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 0.85 | |||||
Beneish M-Score | -2.88 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -16.1 | |||||
3-Year EBITDA Growth Rate | -26.5 | |||||
3-Year Book Growth Rate | -4.5 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 36.11 | |||||
9-Day RSI | 33.46 | |||||
14-Day RSI | 33.05 | |||||
6-1 Month Momentum % | -12.64 | |||||
12-1 Month Momentum % | -25.33 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.5 | |||||
Quick Ratio | 0.3 | |||||
Cash Ratio | 0.09 | |||||
Days Inventory | 82.24 | |||||
Days Sales Outstanding | 52.18 | |||||
Days Payable | 27.02 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -5.21 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 27.63 | |||||
Operating Margin % | -6.14 | |||||
Net Margin % | -7.43 | |||||
FCF Margin % | 7.5 | |||||
ROE % | -3.66 | |||||
ROA % | -2.57 | |||||
ROIC % | -2.67 | |||||
ROC (Joel Greenblatt) % | -1.37 | |||||
ROCE % | -0.9 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1.3 | |||||
PB Ratio | 0.64 | |||||
Price-to-Tangible-Book | 0.65 | |||||
Price-to-Free-Cash-Flow | 17.48 | |||||
Price-to-Operating-Cash-Flow | 16.08 | |||||
EV-to-EBIT | -98.03 | |||||
EV-to-EBITDA | 33.68 | |||||
EV-to-Revenue | 1.94 | |||||
EV-to-FCF | 25.94 | |||||
Price-to-Projected-FCF | 2.1 | |||||
Earnings Yield (Greenblatt) % | -1.02 | |||||
FCF Yield % | 5.82 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Kmpharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 17,769.628 | ||
EPS (TTM) (â‚©) | -47 | ||
Beta | 0.64 | ||
Volatility % | 24.07 | ||
14-Day RSI | 33.05 | ||
14-Day ATR (â‚©) | 19.736765 | ||
20-Day SMA (â‚©) | 854.75 | ||
12-1 Month Momentum % | -25.33 | ||
52-Week Range (â‚©) | 801 - 1450 | ||
Shares Outstanding (Mil) | 27.89 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Kmpharmaceutical Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Kmpharmaceutical Co Ltd Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Kmpharmaceutical Co Ltd Frequently Asked Questions
What is Kmpharmaceutical Co Ltd(XKRX:225430)'s stock price today?
When is next earnings date of Kmpharmaceutical Co Ltd(XKRX:225430)?
Does Kmpharmaceutical Co Ltd(XKRX:225430) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |